Afatinib N-oxide is an active pharmaceutical ingredient metabolite, specifically an oxidized derivative of afatinib. It is a quinazoline-based compound with an N-oxide functional group, characterized by aromatic rings, ether linkages, and halogen substituents.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2413212-11-8
Afatinib impurity 12
Afatinib impurity reference standard
Afatinib Impurity I
pharmaceutical reference standard
N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-4,6-quinazolinediamine
active pharmaceutical ingredient metabolite
1'-hydroxymidazolam
active pharmaceutical ingredient metabolite
2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetic acid
active pharmaceutical ingredient metabolite
Losartan carboxylic acid
active pharmaceutical ingredient metabolite
Isavuconazole
antifungal active pharmaceutical ingredient
Isoconazole nitrate
antifungal active pharmaceutical ingredient
(E)-4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-N,N-dimethyl-4-oxobut-2-en-1-amine oxide
IABSYXLQTGEUIV-CWDCEQMOSA-N
C[N+](C)(C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)[O-]